Diabetes is one of the common health issue faced by more than 80% of the total population today. It is a chronic disease caused by excessive or underproduction of insulin from the pancreas. Diabetes is not just one problem; it is a series of several other serious ailments.The pancreas secrete a hormone called insulin in the body. This insulin uses
Read MoreThe Philips B-Line BFL2114 58" class 4K UHD smart professional LED television offers the best viewing experience when you need to easily share content across multiple devices in your huddle space. Even if you have never used a Philips TV before, there...
Faster shipping. Better service
1000 W La Veta Ave 1st Floor,Orange,CA
The Liver, Bile Duct and Pancreas Tumor Program at St. Joseph Hospital provides high-level care that includes all aspects of patient care, including prevention, early diagnosis and effective treatment. We take an aggressive approach that offers patients the benefits of the latest medical technologies in the diagnosis and treatment of all forms of liver tumors and focus on primary (benign and malignant) and metastatic tumors of the liver and biliary system.
(171) 473 - 4629
200 Medical Plaza Driveway Suite B265 (B2 Level),Los Angeles,CA
James Tomlinson, MD, PhD received his MD from the University of Pennsylvania School of Medicine in 1995. He was trained in General Surgery at UCLA, finishing in 2003. He also obtained his PhD degree in molecular biology at UCLA, and then completed a Surgical Oncology Fellowship at Memorial Sloan Kettering Cancer Center in 2005. Dr. Tomlinson has been Chief of Surgical Oncology, at the VA Greater Los Angeles Healthcare System Medical Center, Los Angeles, CA and Attending Surgeon in the Division of Surgical Oncology at UCLA since 2005. He has an active surgical oncology practice that is focused on pancreatic and biliary cancers. Dr. Tomlinson's basic science research efforts are focused on the development and evaluation of novel targeted imaging agents against pancreas cancer. Currently, he is evaluating the potential of Anti-CA19-9 and Anti-CEA engineered antibody fragments to serve as PET-imaging agents of pancreas cancer. He also performs outcomes research which addresses clinical questions in the management of pancreas cancer.
(131) 082 - 5621
2020 Santa Monica Boulevard Suite 600,Santa Monica,CA
Dr. Zev Wainberg is the Professor of Medicine at UCLA and co-director of the UCLA GI Oncology Program. He was trained in medical oncology and hematology at UCLA. He completed his residency training at Albert Einstein College of Medicine and received his MD from the Sackler School of Medicine, New York Program at Tel Aviv University. His research involves a variety of clinical trials in multiple gastrointestinal cancers including pancreas, colon, gastric and esophageal. Dr. Wainberg's laboratory…
(131) 082 - 9547
2020 Santa Monica Boulevard Suite 600,Santa Monica,CA
Lee Rosen, MD, FACP is Health Sciences Clinical Professor of Medicine in the Division of Hematology-Oncology, Department of Medicine. He has a longstanding interest in the treatment of pancreas and other gastrointestinal malignancies, specifically in the area of new drug development. Dr. Rosen completed his residency and fellowship in hematology/oncology at the UCLA School of Medicine in 1996, joining the full-time faculty immediately thereafter. He created and directed the Cancer Therapy…
(131) 082 - 9547
2121 Santa Monica Boulevard,Santa Monica,CA
Anton J. Bilchik, MD, PhD, MBA, FACS, is a board-certified surgical oncologist in Santa Monica, CA. Dr. Bilchik is Professor of Surgery and Chief of Medicine at the Saint Johns Cancer Institute. He is an internationally recognized surgeon and scientist who has pioneered techniques to improve staging in colon cancer and minimally invasive approaches for liver and pancreas cancer.
(131) 044 - 9520
Copyright 2024. All Rights Reserved.